Our target market encompasses biosensor companies and organizations focused on developing electrodes for assay applications. These entities can significantly benefit from our innovative designs. The biosensor industry, as reported by Markets and Markets, is experiencing robust growth. It is projected to expand from its current valuation to $36.7 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 7.5%. This growth is driven by increasing demand for point-of-care testing, rising prevalence of chronic diseases, and advancements in nanotechnology. Companies within this sector are actively seeking advanced, reliable, and cost-effective electrode solutions to enhance the sensitivity and specificity of their assays, thereby improving diagnostic accuracy and patient outcomes. Our designs are well-positioned to meet these demands, offering cutting-edge technology that aligns with the evolving needs of the biosensor market.
Competitor Analysis
The current competitors for electrode printing include Almax and the Exellia Micropen. Almax specialize in creating flexible circuits either through screen printing or digital printing. Exellia is able to print on 3D surfaces. Both these companies do not specialize in POC electronics.